425: Strive, Semler Scientific Advance Merger Plans

Strive and Semler Scientific are progressing with their proposed business combination, as communicated via an X.com repost by Strive's CEO.

Summary

• A communication regarding the proposed business combination between Strive, Inc. and Semler Scientific, Inc. was reposted on X.com by Matthew Cole, CEO of Strive, Inc., on September 24, 2025.
• The filing includes extensive cautionary statements about forward-looking statements, highlighting inherent risks and uncertainties associated with the proposed transaction.
• It details where additional information, such as the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus, can be obtained from the SEC and company websites.
• The document identifies Strive, Semler Scientific, and certain of their directors, executive officers, and employees as potential participants in the solicitation of proxies from Semler Scientific stockholders for the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a procedural announcement of a proposed merger, heavily weighted with cautionary language and a comprehensive list of risks associated with such a transaction. While it mentions strategic and financial benefits, the emphasis is on potential challenges and uncertainties, leading to a neutral sentiment.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings are a potential positive outcome of the business combination.

Negatives

• The proposed transaction may not close when expected or at all if conditions are not met.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may incur higher expenses or take longer to complete than initially projected.
• Management's attention may be diverted from ongoing business operations and other opportunities.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential for adverse reactions from customers or changes to business or employee relationships exists.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all, including risks associated with Bitcoin treasury strategies and other digital assets.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction include anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. These are forward-looking statements subject to various risks and uncertainties.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted the communication on X.com on September 24, 2025, in connection with the proposed business combination.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity may be pursuing or continuing a strategy involving digital asset holdings, aligning with a broader industry trend of corporate adoption of cryptocurrencies as treasury assets.

Stakeholder Impact

• Shareholders of Strive face potential dilution from the issuance of new Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employees of both companies may experience changes to business or employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, acquisition, SEC filing, Form 425, Bitcoin, digital assets, corporate governance, financial reporting